Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 76

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 76
---
expensive and time-consuming and may result in significant diversion of resources and management attention from NewGenIvf’s business
operations. Furthermore, such legal or administrative actions may adversely affect NewGenIvf’s brand image and reputation.

Certain data and information in this prospectus relied on by NewGenIvf were obtained from third-party data and polls. These metrics were not independently verified by NewGenIvf and may not be accurate.

Certain numbers and information
in this prospectus were obtained and provided from numerous sources including management data, third-party data or numbers generally estimated
by calculating infertile couples, fertility tourism number, etc. to generally assess potential customer numbers in Asia-Pacific countries.

These metrics were not independently
verified. Such databases, third-party information, and calculations may not accurately reflect actual statistics or numbers and NewGenIvf
does not have access to specific rating numbers. Similarly, any statistical data in any third-party publications also include projections
based on a number of assumptions. If any one or more of the assumptions underlying the market data is later found to be incorrect, actual
results may differ from the projections based on these assumptions.

Risks Related to Government Regulation

NewGenIvf operates in a highly regulated industry and must comply with a significant number of complex and evolving requirements. Any lack of requisite approvals, licenses, or permits applicable to NewGenIvf’s business may have a material and adverse impact on NewGenIvf’s business, financial condition, and results of operations.

The operations of NewGenIvf
are subject to various laws, rules and regulations at the national, regional and local levels in Thailand, Cambodia, Kyrgyzstan, Hong
Kong, United Arab Emirates, United States of America and other applicable jurisdictions. Such laws and regulations mainly relate to (i) the
licensing of local and foreign medical professionals, nursing professionals, medical technology professionals, pharmaceutical professions
and other applicable licensing; (ii) the licensing, registration, and accreditation of medical facilities, laboratories, including
but not limited to the licensing, registration, and accreditation of persons performing related activities; (iii) the privacy and
security of confidential patient medical records; (iv) the corporate practice of medicine; (v) healthcare fraud and abuse laws;
(vi) the donation and transplantation of human cells, tissues and organs; (vii) potential prohibition on surrogacy or providing
intermediary assistance in surrogacy; and (viii) licensing and approval of the accommodation provided as parts of the services